NCT04372394View on ClinicalTrials.gov

A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

October 31, 2020

Study Completion Date

March 2, 2021

Conditions
Healthy
Interventions
DRUG

surufatinib

Surufatinib: 300 mg as a single dose on Days 1 and 8 with or without food

Trial Locations (1)

75247

Covance Clinical Research Unit, Dallas

All Listed Sponsors
lead

Hutchison Medipharma Limited

INDUSTRY

NCT04372394 - A Study to Assess the Effect of a High Fat Meal on Surufatinib in Healthy Subjects | Biotech Hunter | Biotech Hunter